Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study

Journal of Alzheimer's Disease

Volumn 47, Issue 1, 2015, Pages 197-204

  Nishtala, Arvind ^a   Himali, Jayandra J ^a   Beiser, Alexa ^a,b   Murabito, Joanne M ^a   Seshadri, Sudha ^a   Wolf, Philip A ^a   Au, Rhoda ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apolipoprotein E4; Blood pressure; Cognition; Executive function; Hypertension; Memory; Neuropsychological assessment

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED WORD ASSOCIATION TEST; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FRAMINGHAM RISK SCORE; HOOPER VISUAL ORGANIZATION TEST; HUMAN; HYPERTENSION; INTELLIGENCE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIDLIFE HYPERTENSION; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRAIL MAKING TEST; VERBAL COMMUNICATION; VERY ELDERLY; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; GENETICS; MASSACHUSETTS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84940925660     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141881     Document Type: Article

References (37)

1. Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S,Willcox D, Ohya Y, Willcox BJ, Dodge HH (2012) Metabolic syndrome and cognitive decline among the oldest old in Okinawa: In search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci 67, 126-134.
2. Lucca U, Garrì M, Recchia A, Logroscino G, Tiraboschi P, Franceschi M, Bertinotti C, Biotti A, Gargantini E, Maragna M, Nobili A, Pasina L, Franchi C, Riva E,TettamantiM(2011) A Population-based study of dementia in the oldest old: The Monzino 80-plus study. BMC Neurol 11, 54.
3. Kinsella K, Wan H (2009) An Aging World: 2008, https:// www.census.gov/prod/2009pubs/p95-09-1.pdf. Posted June 2009, Accessed May 24, 2013.
4. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, Wright LR, Havlik RJ (2000) Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 21, 49-55.
5. Kivipelto M, Helkala EL, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 322, 1447-1451.
6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64, 277-281.
7. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y (2003) Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 72, 1125-1133.
8. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: The Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51, 410-414.
9. Launer LJ, Masaki K, Petrovitch H, Foley D,Havlik RJ (1995) The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 274, 1846-1851.
10. Kivipelto M, Helkala EL, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 56, 1683-1689.
11. Swan GE, DeCarli C, Miller BL, Reed T,Wolf PA, Jack LM, Carmelli D (1998) Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51, 986-993.
12. Swan GE, Carmelli D, LarueA(1998) Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 29, 2334-2340.
13. Elias MF,Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 138, 353-364.
14. Elias PK, Elias MF, Robbins MA, Budge MM (2004) Blood pressure-related cognitive decline: Does age make a difference? Hypertension 44, 631-636.
15. Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G (2011) Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 77, 1729-1736.
16. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. (1998) Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 31, 780-786.
17. Kilander L, Nyman H, Boberg M, Lithell H (2000) The association between low diastolic blood pressure in middle age and cognitive function in old age. A population-based study. Age Ageing 29, 243-248.
18. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77, 461-468.
19. Peltz CB, Corrada MM, Berlau DJ, Kawas CH (2012) Cognitive impairment in nondemented oldest-old: Prevalence and relationship to cardiovascular risk factors. Alzheimers Dement 8, 87-94.
20. Richmond R, Law J, Kay-Lambkin F (2011) Higher blood pressure associated with higher cognition and functionality among centenarians in Australia. Am J Hypertens 24, 299-303.
21. Szewieczek J, Dulawa J, Gminski J, Kurek A, Legierska K, Francuz T, Wlodarczyk-Sporek I, Janusz-Jenczen M, Hornik B (2011) Better cognitive and physical performance is associated with higher blood pressure in centenarians. J Nutr Health Aging 15, 618-622.
22. Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U (2007) Low systolic blood pressure is associated with impaired cognitive function in the oldest old: Longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 19, 41-47.
23. Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C,Wolf PA, DeCarli C, MilbergW(2010) Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes. J Stroke Cerebrovasc Dis 19, 261-268.
24. Peila R, White LR, Petrovich H, Masaki K, Ross GW, Havlik RJ, Launer LJ (2001) Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia aging study. Stroke 32, 2882-2889.
25. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282, 40-46.
26. Carmelli D, Swan GE, Reed T, Miller B,Wolf PA, Jarvik GP, Schellenberg GD (1998) Midlife cardiovascular risk factors, Apo E, and cognitive decline in elderly male twins. Neurology 50, 1580-1585.
27. Qiu C, Winblad B, Fratiglioni L (2006) Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population. Neurol Res 28, 650-656.
28. Au R, Seshadri S,Wolf PA, Elias M, Elias P, Sullivan L, Beiser A, D'Agostino RB (2004) New norms for a new generation: Cognitive performance in the Framingham offspring cohort. Exp Aging Res 30, 333-358.
29. Manly JJ, Jacobs DM, Touradji P, Small SA, Stern Y (2002) Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc 8, 341-348.
30. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56, 42-48.
31. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2003) Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study. Int J Obes Relat Metab Disord 27, 260-268.
32. Piguet O, Grayson DA, Creasey H, Bennett HP, Brooks WS, Waite LM, Broe GA (2003) Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology 22, 165-171.
33. Guo Z, Fratiglioni L, Winblad B, Viitanen M (1997) Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 145, 1106-1113.
34. Kahonen-VareMB-H(2004) Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. Aging Clin Exp Res 16, 147-152.
35. Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease. JAMA Neurol 70, 440-444.
36. Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50, S183-S188.
37. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303.